These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Diabetes mellitus and obesity]. MMW Munch Med Wochenschr; 1980 Jan; 122(3):70-3. PubMed ID: 6767927 [No Abstract] [Full Text] [Related]
45. Improvement of fat redistribution, insulin resistance and hepatic fatty infiltration in HIV-associated lipodystrophy syndrome by pioglitazone: a case report. Prasithsirikul W; Bunnag P J Med Assoc Thai; 2004 Feb; 87(2):166-72. PubMed ID: 15061300 [TBL] [Abstract][Full Text] [Related]
46. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782 [TBL] [Abstract][Full Text] [Related]
47. [Diagnostic significance of serum -glucuronidase. IV. Serum -glucuronidase activity in arteriosclerosis and diabetes mellitus]. Nilius R; Krosch H; Zipprich KW Z Gesamte Inn Med; 1971 Jun; 26(12):393-7. PubMed ID: 4256412 [No Abstract] [Full Text] [Related]
48. Hepatic complications of obesity. Diehl AM Gastroenterol Clin North Am; 2005 Mar; 34(1):45-61. PubMed ID: 15823438 [TBL] [Abstract][Full Text] [Related]
49. Pathohistological study on liver cirrhosis in diabetes mellitus. Hano T Kobe J Med Sci; 1968 Jun; 14(2):87-106. PubMed ID: 5704884 [No Abstract] [Full Text] [Related]
50. Fatty liver: a novel component of the metabolic syndrome. Kotronen A; Yki-Järvinen H Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):27-38. PubMed ID: 17690317 [TBL] [Abstract][Full Text] [Related]
51. [Complications of obesity--pathogenesis]. Krahulec B Vnitr Lek; 2010 Oct; 56(10):1050-2. PubMed ID: 21105450 [TBL] [Abstract][Full Text] [Related]
52. Obesity and the metabolic syndrome. Vega GL Minerva Endocrinol; 2004 Jun; 29(2):47-54. PubMed ID: 15257255 [TBL] [Abstract][Full Text] [Related]
53. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives. Federico A; Trappoliere M; Loguercio C Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661 [TBL] [Abstract][Full Text] [Related]
54. The metabolic consequences of childhood obesity. Weiss R; Caprio S Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):405-19. PubMed ID: 16150383 [TBL] [Abstract][Full Text] [Related]
55. Nonalcoholic fatty liver disease in children. Mager DR; Roberts EA Clin Liver Dis; 2006 Feb; 10(1):109-31, vi-vii. PubMed ID: 16376797 [TBL] [Abstract][Full Text] [Related]
56. Review article: steatosis, the metabolic syndrome and cancer. Bugianesi E Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():40-3. PubMed ID: 16225471 [TBL] [Abstract][Full Text] [Related]
57. [State of the liver in diabetes mellitus]. Zaĭchikova VI Ter Arkh; 1969; 41(10):85-90. PubMed ID: 5359354 [No Abstract] [Full Text] [Related]
58. [Nonalcoholic steatohepatitis. Three case reports]. Eivindson MV; Hamilton-Dutoit S; Grønbaek H Ugeskr Laeger; 2003 Mar; 165(11):1118-20. PubMed ID: 12677986 [TBL] [Abstract][Full Text] [Related]
59. The liver and the waistline: Fifty years of growth. Farrell GC J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S105-18. PubMed ID: 19799688 [TBL] [Abstract][Full Text] [Related]
60. [Significance of fatty liver as an early symptom of diabetes mellitus and hyperlipoproteinemias]. Hanefeld M; Haller H; Renger F; Stötzner H Dtsch Z Verdau Stoffwechselkr; 1974; 34(5-6):299-300. PubMed ID: 4471587 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]